GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation

OSL:GENT • NO0010748866

Current stock price

44.3 NOK
+1.8 (+4.24%)
Last:

This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. GENT.OL Profitability Analysis

1.1 Basic Checks

  • GENT had positive earnings in the past year.
  • GENT had a positive operating cash flow in the past year.
  • In multiple years GENT reported negative net income over the last 5 years.
  • In multiple years GENT reported negative operating cash flow during the last 5 years.
GENT.OL Yearly Net Income VS EBIT VS OCF VS FCFGENT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • GENT has a better Return On Assets (5.13%) than 69.84% of its industry peers.
  • The Return On Equity of GENT (6.47%) is comparable to the rest of the industry.
  • GENT has a better Return On Invested Capital (8.73%) than 74.60% of its industry peers.
Industry RankSector Rank
ROA 5.13%
ROE 6.47%
ROIC 8.73%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENT.OL Yearly ROA, ROE, ROICGENT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.51%, GENT is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 14.42%, GENT is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • With a Gross Margin value of 55.64%, GENT perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GENT has grown nicely.
Industry RankSector Rank
OM 14.42%
PM (TTM) 7.51%
GM 55.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
GENT.OL Yearly Profit, Operating, Gross MarginsGENT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. GENT.OL Health Analysis

2.1 Basic Checks

  • GENT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for GENT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GENT.OL Yearly Shares OutstandingGENT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
GENT.OL Yearly Total Debt VS Total AssetsGENT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • GENT has an Altman-Z score of 8.75. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
  • GENT's Altman-Z score of 8.75 is amongst the best of the industry. GENT outperforms 93.65% of its industry peers.
  • GENT has a debt to FCF ratio of 0.61. This is a very positive value and a sign of high solvency as it would only need 0.61 years to pay back of all of its debts.
  • The Debt to FCF ratio of GENT (0.61) is better than 93.65% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that GENT is not too dependend on debt financing.
  • GENT's Debt to Equity ratio of 0.09 is amongst the best of the industry. GENT outperforms 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.61
Altman-Z 8.75
ROIC/WACC1.02
WACC8.53%
GENT.OL Yearly LT Debt VS Equity VS FCFGENT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • GENT has a Current Ratio of 5.40. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of GENT (5.40) is better than 96.83% of its industry peers.
  • A Quick Ratio of 3.81 indicates that GENT has no problem at all paying its short term obligations.
  • The Quick ratio of GENT (3.81) is better than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 5.4
Quick Ratio 3.81
GENT.OL Yearly Current Assets VS Current LiabilitesGENT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GENT.OL Growth Analysis

3.1 Past

  • The earnings per share for GENT have decreased strongly by -70.75% in the last year.
  • Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 16.07% in the last year.
  • The Revenue has been growing by 22.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 79.21% on average over the next years. This is a very strong growth
  • GENT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.00% yearly.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. GENT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 52.12 indicates a quite expensive valuation of GENT.
  • Based on the Price/Earnings ratio, GENT is valued a bit more expensive than 61.90% of the companies in the same industry.
  • GENT is valuated expensively when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 16.58, GENT is valued correctly.
  • 65.08% of the companies in the same industry are more expensive than GENT, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, GENT is valued rather cheaply.
Industry RankSector Rank
PE 52.12
Fwd PE 16.58
GENT.OL Price Earnings VS Forward Price EarningsGENT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GENT is on the same level as its industry peers.
  • GENT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GENT is cheaper than 74.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.52
EV/EBITDA 17.31
GENT.OL Per share dataGENT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as GENT's earnings are expected to grow with 79.21% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GENT.OL Dividend Analysis

5.1 Amount

  • GENT has a Yearly Dividend Yield of 1.41%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of GENT has falen by -24.40%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • GENT's Dividend Yield is a higher than the industry average which is at 1.22.
  • GENT's Dividend Yield is slightly below the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • GENT pays out 46.54% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Yearly Income VS Free CF VS DividendGENT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M
GENT.OL Dividend Payout.GENT.OL Dividend Payout, showing the Payout Ratio.GENT.OL Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GENT.OL Fundamentals: All Metrics, Ratios and Statistics

GENTIAN DIAGNOSTICS ASA

OSL:GENT (4/17/2026, 7:00:00 PM)

44.3

+1.8 (+4.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap684.88M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (45.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.56%
Valuation
Industry RankSector Rank
PE 52.12
Fwd PE 16.58
P/S 3.88
P/FCF 21.52
P/OCF 16.08
P/B 3.34
P/tB 4.05
EV/EBITDA 17.31
EPS(TTM)0.85
EY1.92%
EPS(NY)2.67
Fwd EY6.03%
FCF(TTM)2.06
FCFY4.65%
OCF(TTM)2.75
OCFY6.22%
SpS11.42
BVpS13.26
TBVpS10.94
PEG (NY)0.25
PEG (5Y)N/A
Graham Number15.9231 (-64.06%)
Profitability
Industry RankSector Rank
ROA 5.13%
ROE 6.47%
ROCE 11.34%
ROIC 8.73%
ROICexc 16.54%
ROICexgc 23.72%
OM 14.42%
PM (TTM) 7.51%
GM 55.64%
FCFM 18.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.61
Debt/EBITDA 0.56
Cap/Depr 118.04%
Cap/Sales 6.1%
Interest Coverage 250
Cash Conversion 123.21%
Profit Quality 240.13%
Current Ratio 5.4
Quick Ratio 3.81
Altman-Z 8.75
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A

GENTIAN DIAGNOSTICS ASA / GENT.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.


Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.


What is the profitability of GENT stock?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.


What are the PE and PB ratios of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?

The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 52.12 and the Price/Book (PB) ratio is 3.34.


What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?

The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.